Related Experiment Videos

The differing outcomes of hyperthyrotropinaemia

Declan Cody1, Yadlapalli Kumar, Sze May Ng

  • 1Royal Liverpool Children's NHS Trust, UK. declan.cody@btopendworld.com

Journal of Pediatric Endocrinology & Metabolism : JPEM
|April 23, 2003
PubMed

Insights

Persistent hyperthyrotropinaemia in children, a condition with normal thyroxine (T4) and raised thyroid-stimulating hormone (TSH), requires ongoing monitoring. Most children exhibit normal development, but continued thyroid function tests are recommended until TSH levels normalize.

Area of Science:

  • Pediatric Endocrinology
  • Neonatal Screening
  • Thyroid Function Tests

Background:

  • Hyperthyrotropinaemia (elevated TSH with normal T4) is detected via neonatal screening.
  • The long-term outcomes for children with persistent hyperthyrotropinaemia remain unclear.
  • This condition necessitates careful evaluation of its developmental impact.

Purpose of the Study:

  • To assess the developmental outcomes of children diagnosed with persistent hyperthyrotropinaemia.
  • To understand the long-term trajectory of thyroid function in affected children.
  • To inform clinical management guidelines for this condition.

Main Methods:

  • Retrospective analysis of pediatric patients diagnosed with hyperthyrotropinaemia over 20 years.
  • Inclusion criteria: diagnosis of hyperthyrotropinaemia lasting over 3 months.
  • Data collection focused on thyroid function test trends, growth, and developmental milestones.

Main Results:

  • Eight children were identified with hyperthyrotropinaemia exceeding 3 months.
  • Four cases presented with a transient form (3-18 months).
  • Three children maintained persistently elevated TSH at ages 5, 9, and 17; one developed hypothyroidism requiring thyroxine replacement.
  • All participants demonstrated normal growth and development.

Conclusions:

  • Children with persistent hyperthyrotropinaemia generally show normal growth and development.
  • Continuous monitoring of thyroid function is crucial until thyroid-stimulating hormone (TSH) levels normalize.
  • Early detection through neonatal screening allows for timely intervention and management.

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...